etectRx
its ID-Cap ingestible event marker confirms medication ingestion for adherence monitoring, with active clinical studies including a UCLA study on HIV care and the University of Colorado's QUANTI-TAF study.
- Country
- United States
Growth
ID-Cap ingestible event marker
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Ingestible biosensors / smart pills | diagnostics-medtech | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.